コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 g policy as a result of the backlash against managed care.
2 icists--to develop a statement of ethics for managed care.
3 ions about quality, and dissatisfaction with managed care.
4 he VA system than for patients in commercial managed care.
5 p to avoid a large proportion of disputes in managed care.
6 eficiaries who were and were not enrolled in managed care.
7 l disparity in vaccination is not reduced in managed care.
8 re African American and 11% were enrolled in managed care.
9 ment, collaborative care, enhanced care, and managed care.
10 s may not be fulfilled due to pressures from managed care.
11 o substance abuse treatment after a shift to managed care.
12 ars and enrolled in Medicare FFS or Medicare managed care.
13 1994 to 7.7% in 1997, following the shift to managed care.
14 f the same specific clinical competencies in managed care.
15 service medicine, and 29.3 percent preferred managed care.
16 ine their experiences in and perspectives on managed care.
17 zations can be influenced by the presence of managed care.
18 service medicine, and 20.5 percent preferred managed care.
19 atient-physician relationship as a result of managed care.
20 cost-effectiveness depend on good clinically managed care.
21 determine how best to inform patients about managed care.
22 for-service care, and 30.8 percent preferred managed care.
23 triage systems currently evolving as part of managed care.
24 us financial risks for AMCs participating in managed care.
25 difference in societal costs associated with managed care.
26 , Diagnostic, and Treatment dental services; managed care accountability; integration of medical and
27 y enrollment rate and two measures of county managed care activity (penetration and index of competit
30 viously documented negative attitudes toward managed care among academic physicians may obscure an un
32 arize some of the complex issues surrounding managed care and discuss the resultant changes in anesth
33 variation of health plan exit from Medicaid managed care and evaluate the relationship between healt
34 care utilization and outcomes of persons in managed care and fee-for-service after adjusting for dif
36 between patients in HMOs and those in other managed care and fee-for-service settings in rates of in
37 y to use biologic agents than those in other managed care and fee-for-service settings, primarily due
38 d other treatments among patients with RA in managed care and fee-for-service settings, with and with
40 he current and potential long-term impact of managed care and other system changes on the practice of
41 ween financial and administrative aspects of managed care and physicians' concern about the scope of
42 mics, discussing physician organizations and managed care, and a medical ethics evaluation of medical
43 o understand and exercise other rights under managed care, and discourage use of compensation methods
44 with changes in reimbursement, increases in managed care, and growth in the prescription of medicati
46 d whether the ascendancy of computerization, managed care, and the adoption of more businesslike appr
47 ed antidepressants, increased penetration of managed care, and the development of rapid and efficient
49 ing caused by the transition into a Medicaid managed care arrangement or Medicaid ineligibility (the
52 dvisory patterns using a national integrated managed care claims database from July 1999 through June
53 fter an acute hospitalization at a time when managed care companies and others increasingly hold hosp
54 5 to 64 years belonging to a large, national managed care company from January 1, 2005, to December 3
55 In the multivariate model, greater county managed care competition (IOC) was inversely related to
56 counties, and counties with higher levels of managed care competition had significantly lower enrollm
57 was Kaiser Permanente Hawaii, an integrated managed care consortium that serves approximately 15% of
61 re conducted using data from a US integrated managed care database (PharMetrics claims database) from
62 tive cohort analysis using data from a large managed care database (PharMetrics, 2000-2006), patients
65 f patients with RA in managed care, those in managed care did not differ from those in fee-for-servic
66 therapy visits in 1999, patients with RA in managed care did not report significantly different util
70 D who were commercially insured and Medicare managed care enrollees from a large, national US managed
78 ve), more fee-for-service beneficiaries than managed-care enrollees underwent angiography (46 percent
80 to prepare physicians to work effectively in managed care environments, managed care is often perceiv
85 ectors, and department chairs responded that managed care had reduced the time they had available for
95 beneficiaries who were enrolled in Medicare managed care health plans had data for at least 1 of the
97 Among Medicare beneficiaries enrolled in managed care health plans, blacks received poorer qualit
100 e-for-service medicine was rated better than managed care in terms of access (by 80.2 percent of resp
101 section is important from the perspective of managed care in the United States and for the commission
104 nsurance (n = 18,905), patients with private managed care insurance (n=7169) and Medicare managed car
105 managed care insurance (n=7169) and Medicare managed care insurance (n=880) were less likely to recei
106 , we examined whether patients with Medicare managed care insurance enrolled in hospice earlier and h
107 New York State; however, the extent to which managed care insurance plans direct enrollees to the low
108 State with private managed care and Medicare managed care insurance were significantly less likely to
110 ly to undergo reconstruction than those with managed care insurance; however, there was no difference
115 rk effectively in managed care environments, managed care is often perceived negatively by academic p
118 r data indicate that residency directors and managed care medical directors value mastery of many of
119 ps," on drug benefits are common in Medicare managed care (Medicare + Choice) and have been part of s
120 s' experiences with health care for Medicare managed care (MMC) and traditional fee-for-service (FFS)
123 ir scope of practice, and a proliferation of managed-care models that emphasized the use of these pro
124 ntinuously enrolled in a large nationwide US managed care network and who visited an eye care profess
125 ed for more than 6 months in a nationwide US managed care network between 2001 and 2011 in communitie
126 olled for 3 or more years in a nationwide US managed care network between January 1, 2001, and Decemb
129 55 years who were continuously enrolled in a managed care network for at least 2 years and who had >/
130 o were continuously enrolled in a particular managed care network for at least 5 years between Januar
131 th newly diagnosed diabetes enrolled in a US managed care network from January 1, 2001, through Decem
132 d no preexisting record of OAG in a large US managed care network from January 1, 2001, through Decem
133 ctomy rates per 1000 enrollees in this large managed care network over the course of the past decade.
136 ims data from a large national United States managed care network were reviewed to identify Asian Ame
137 G patients enrolled in a large United States managed care network were reviewed to identify glaucoma-
138 nrollees in a large nationwide United States managed care network with newly diagnosed acute conjunct
140 cataracts who were enrolled in a nationwide managed-care network during the period from 2001 to 2011
141 of almost 8 million enrollees in a national managed-care network throughout the United States who ha
142 sons continuously enrolled for 11 years in a managed-care network were searched for International Cla
145 ood out as a low and slow payer, but neither managed care nor Medicare had a consistent effect on fin
147 Respondents rated their attitudes toward managed care on a 0-to-10 scale, with 0 defined as "as n
148 ad better scores than patients in commercial managed care on all process measures (for example, 93% v
151 assessed the trends for visits covered by a managed-care or other prepaid health plan (prepaid visit
152 rospective study was done among members of a managed care organization in Minneapolis/St. Paul, Minne
154 t Kaiser Permanente Hawaii, a multispecialty managed care organization serving approximately 15% of t
155 he case patients were matched to controls by managed care organization site, sex, and age at the inde
160 ical records of 452 patients from a regional managed care organization with >/=3 consecutive NSAID pr
161 rom Kaiser Permanente Southern California, a managed care organization with more than 3 million membe
162 -years]), was evaluated using records from a managed care organization with nearly 20 community hospi
165 patients with heart failure in an integrated managed care organization, low health literacy was signi
169 isits (1996-1999) from a large Massachusetts managed care organization/multispecialty practice group
172 e in the relationship between themselves and managed care organizations (MCOs), including how it can
174 crete definition of primary care has allowed managed care organizations and payers, among others, to
176 years of age or older who were enrolled in 2 managed care organizations and received care between Jul
178 care for individuals who are not covered by managed care organizations can be influenced by the pres
179 older who were continuously enrolled in the managed care organizations from 1 July 1998 to 31 July 1
180 Consecutive patients (N=27,332) from six managed care organizations in five states were screened,
181 ician visits were obtained from Medicare and managed care organizations in the Philadelphia region.
182 f significant medically attended events at 8 managed care organizations in the United States that com
183 ieties, influenza vaccine manufacturers, and managed care organizations met to assess whether current
188 seniors (adults aged >/=65 years) from 7 US managed care organizations that participated in the Vacc
189 with the vision behind the creation of HMOs, managed care organizations that were once embraced by ph
190 ct that the new HEDIS measure will encourage managed care organizations to develop systems that impro
191 well as court decisions increasingly require managed care organizations to disclose physician financi
193 the generalizability of these findings in 2 managed care organizations to the general geriatric popu
194 m 46 primary care practices in 6 nonacademic managed care organizations were enrolled in a randomized
195 fairs (VA) with that delivered in commercial managed care organizations, nor have studies focused in
196 ervice to patients, surgeons, hospitals, and managed care organizations, thereby securing the future
201 of community-dwelling members of three large managed-care organizations who were at least 65 years ol
207 teristics, process of care, and outcomes for managed care patients who received new antidepressant pr
210 , physicians who practice in areas with high managed care penetration provided fewer hours of charity
211 showed that departments with medium to high managed care penetration reported more dissatisfaction i
212 ns and those who practice in areas with high managed care penetration tend to provide less charity ca
214 ncology from areas with low, medium, or high managed care penetration were asked to complete a questi
215 tics, and local market factors (for example, managed care penetration); the difference in perceived a
216 tile v lowest quartile) after accounting for managed care penetration, proportion uninsured, and othe
219 epair with vitrectomy among a large group of managed care plan beneficiaries throughout the United St
220 rs who were enrolled in a United States (US)-managed care plan for >/=7 years between 2001 and 2012 a
223 Since the study was done in the context of a managed care plan in one geographic area, it could not a
224 Claims data from a large California Medicaid managed care plan that began offering teledermatology as
226 rom women 50 years or older enrolled in a US managed-care plan for at least 4 years in which enrollee
229 pective cohort of all comprehensive Medicaid managed care plans (N = 390) during the interval 2006-20
232 our findings raise the possibility that some managed care plans are more successful at facilitating o
233 rom a national integrated claims database of managed care plans from October 1998 to September 2005 (
234 large national integrated claims database of managed care plans from October 1998 to September 2005 (
235 ysicians to collectively negotiate fees with managed care plans has been introduced in 10 state legis
238 This was the case well before the rules of managed care plans required patients to align themselves
239 at least 85% of their practice revenue from managed care plans were considerably less likely to prov
241 tion of approximately 800,000 members from 4 managed care plans, we identified patients who had at le
244 aid and commercial populations in 3 types of managed care plans: Medicaid-only plans (serving predomi
247 f care for elderly Medicare beneficiaries in managed-care plans improved substantially from 1997 to 2
248 ten among Medicare beneficiaries enrolled in managed-care plans than among those with fee-for-service
249 rmed less frequently in patients enrolled in managed-care plans than in those with fee-for-service co
250 and black beneficiaries enrolled in Medicare managed-care plans who were eligible for at least one of
254 ted foreclosure among a continuously insured managed-care population of persons with type 2 diabetes
255 pressed primary care patients implemented by managed care practices can improve health outcomes 5 yea
257 <15 years) enrolled in Tennessee's Medicaid Managed Care Program in the 4 study counties, representi
260 potentially duplicative funds in 2 separate managed care programs for the care of same individuals.
263 s had a mean of greater than 10% of Medicaid managed care recipients enrolled in plans that exited, w
264 p of stakeholders--patients, physicians, and managed care representatives, along with medical ethicis
265 0%) household survey respondents, 51 (23.4%) managed care respondents, and 173 (57.7%) NYU Langone re
270 y to use biologic agents than those in other managed care settings (difference of -6.6%; 95% confiden
271 5%; 95% CI -19.0%, -5.9%); patients in other managed care settings and fee-for-service did not differ
272 ignificantly less likely than those in other managed care settings to initiate the use of biologic ag
273 ors, and corticosteroids than those in other managed care settings; they were also less likely to use
275 Managed care status in 1994, and change in managed care status between 1994 and 1999, were not asso
277 te the impact of health insurance status and managed care status on the health care expenditures of t
278 003 household survey [n = 119] and 2004-2005 managed care subscriber survey [n = 218]) who completed
279 sons who were enrolled in one large regional managed care system and treated for AF during calendar y
281 s in a geographically dispersed 280-hospital managed-care system from 2005 to 2014 were reviewed.
284 iews office economics, this year focusing on managed care, the physician workforce, practice manageme
285 wth in the proportion of patients with RA in managed care, those in managed care did not differ from
289 fferences in readmission rates were seen for managed care versus fee-for-service or capitated versus
290 extensively on self-pay patients, had fewer managed-care visits, and prescribed medications in fewer
291 uartile range) length of stay was longer for managed care vs FFS patients (32 days [11-82] vs 25 days
292 Hospice enrollment and length of stay among managed care vs FFS patients differed significantly by r
298 as possible." The expressed attitudes toward managed care were negative, ranging from a low mean (+/-
300 The changes in the sources of payment and managed care will directly affect the economics of a phy
WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。